Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
CRISPR Therapeutics | CRSP | Jan 31, 2025 | 41.59 | -1.07 |
Criteo ADR | CRTO | Jan 31, 2025 | 37.99 | +0.03 |
Critical Metals | CRML | Jan 31, 2025 | 7.72 | -0.39 |
Crocs | CROX | Jan 31, 2025 | 102.07 | -4.62 |
Cronos Group | CRON | Jan 31, 2025 | 1.90 | -1.55 |
Cross Country Healthcare | CCRN | Jan 31, 2025 | 18.22 | -0.11 |
Cross Timbers Royalty Royalty Trust | CRT | Jan 31, 2025 | 10.49 | -1.96 |
CrossAmerica Partners LP Unit | CAPL | Jan 31, 2025 | 23.28 | +0.43 |
CrossFirst Bankshares | CFB | Jan 31, 2025 | 16.24 | 0.00 |
CrowdStrike A | CRWD | Jan 31, 2025 | 398.07 | +0.30 |
Crown Castle | CCI | Jan 31, 2025 | 89.28 | +0.28 |
Crown Crafts | CRWS | Jan 31, 2025 | 4.50 | 0.00 |
Crown ElectroKinetics | CRKN | Jan 31, 2025 | 6.11 | -7.84 |
Crown Holdings | CCK | Jan 31, 2025 | 87.86 | -0.84 |
Crown LNG | CGBS | Jan 31, 2025 | 0.41 | -5.82 |
Cryo-Cell International | CCEL | Jan 31, 2025 | 7.79 | 0.00 |
CryoPort | CYRX | Jan 31, 2025 | 7.54 | -2.46 |
CS Disco | LAW | Jan 31, 2025 | 5.04 | -2.14 |
CSG Systems International | CSGS | Jan 31, 2025 | 58.79 | +1.29 |
CSP | CSPI | Jan 31, 2025 | 19.98 | +14.04 |
CSW Industrials | CSWI | Jan 31, 2025 | 329.81 | +0.52 |
CSX | CSX | Jan 31, 2025 | 32.87 | +0.03 |
CTO Realty Growth | CTO | Jan 31, 2025 | 19.63 | +0.41 |
CTO Realty Growth A Pref | CTO-A | Jan 31, 2025 | 22.65 | +1.21 |
CTRL Group | MCTR | Jan 31, 2025 | 5.20 | 0.00 |
CTS | CTS | Jan 31, 2025 | 51.09 | -0.27 |
CubeSmart | CUBE | Jan 31, 2025 | 41.70 | -0.64 |
Cue Biopharma | CUE | Jan 31, 2025 | 1.45 | +6.62 |
Cullen Frost Bankers B Pref | CFR-B | Jan 31, 2025 | 18.33 | -0.27 |
Cullen/Frost Bankers | CFR | Jan 31, 2025 | 139.40 | -0.80 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.